Biotech · Private company · Vestavia Hills, AL, US
Caladan Therapeutics, Inc.
Track this companyFree. Adds Caladan Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Meganuclease-mediated gene editing for durable control of HSV-2 infectionFiscal year 2025 · $303.7KNIH RePORTER 5R41AI186683-02 · fetched Nov 12, 2026
- Meganuclease-mediated gene editing for durable control of HSV-2 infectionFiscal year 2024 · $303.7KNIH RePORTER 1R41AI186683-01 · fetched Nov 12, 2026